Clinical Research Associate CRA - Career, Jobs, Certification, Industry Insight.

Insight into the World of Clinical Research From a CRA

  • Clinical Trial Basics
    • Drug Development
    • Medical Device Development
    • In Vitro Diagnostic Development
  • Industry Players
    • Sponsor
    • Clinical Site
    • Contract Research Organization (CRO)
    • Site Management Organization (SMO)
    • Institutional Review Board (IRB) or Ethics Review Committee (ERC)
    • Regulatory Body
  • CRA Career Path
    • What is CRA?
    • Education and Skills Needed
    • How to Get Into a CRA Role
    • Career Development
    • CRA Certification
  • Clinical Research Regulations
    • Historical Events behind Current Regulations
    • Food and Drug Administration (FDA)
    • ICH’s GCP Guideline
    • European Medicines Agency (EMA)
    • Country Specific Regulations – Global / International Trial
  • Resources
    • ES’ SOCRA CCRP Exam Study Guide
    • Purchasing Multiple Copies of the ES’ SOCRA CCRP Study Guide
    • Email/Download Troubleshoot & FAQs for ES’ SOCRA CCRP Study Guide
    • Books
    • Jobs
  • About
  • Contact
You are here: Home / Country Specific Regulations – Global / International Trial

Country Specific Regulations – Global / International Trial

As more and more clinical trials become globalized, regulatory pathways in different region and countries represent both opportunities and limitations in the continuation of this trend. One important point to bring up in global trial discussion is that outside of the European Union (EU), there is no harmonization of regulatory requirements among each country. Thus, country specific regulatory requirements are the rules governing clinical trial conducts and final product approvals.

Commercial Opportunities

Developing countries represent significant opportunities due to the large size of population (potential buyers of the product) in different regions of the world. In addition, the size of the market in some regions is growing rapidly.  For example, Asian pharmaceutical market is already substantial, second only to that of North America. China, alone, is growing rapidly due to its vast population.

Non-Commercial Opportunities

In addition to commercial potential, developing countries also present non-commercial opportunities such as access to:

  • New patient / disease populations
  • New clinical trial sites
  • Key opinion leaders (KOLs)
  • New regions with potentially lower clinical trial cost

Consideration for Global Trial Site Selection

When considering global / international clinical trial site(s), manufacturers must consider the factors below:

  • Which countries should (and should not) be included in global development plans
  • When these countries should be involved, as each country requires different timelines for clinical trial approvals, completion, and regulatory and reimbursement decisions
  • How the manufacturer should be involved in the end market use of the product in these countries. Examples include how the end product will be distribute, the cost of the product, and the unmet need in different countries

Country Specific Regulation

Efficiency and review process among countries are different, which lead to significant variation on regulatory pathways from country to country. Below are some examples of time for review and approval for a clinical trial application for some countries:

Country Regulatory Authority Time to review and approve a clinical trial application (Weeks) Time to review/approve a New Chemical Entity (NCE) (Months) Dossier Type Local Trial Required for Approval Local Post-Marketing Safety Studies Required
Australia Therapeutic Goods Administration (TGA) 18 [ethics = 12-16 + regulatory = 2] 13-15 ICH No Yes
China China Food and Drug Administration (CFDA) 64 [regulatory =  40-56 + ethics = 4-8] 21-25 ICH Yes  Yes
India Drug Controller General of India (DCGI) 24-32 [parallel; regulatory = 16-18, ethics = 6-10] 12 ICH Yes Yes
Japan Ministry of Health, Labor and Welfare (MHLW) 4.3+[regulatory = 4.3+ethics] 12 ICH Yes Yes
New Zealand New Zealand Medicines and Medical Devices Safety Authority (Medsafe) 4-6 [parallel; regulatory = 4-6, ethics = 4-6] 11 ICH No No
South Korea Ministry of Food and Drug Safety (MFDS) 8 [parallel; regulatory = 8, ethics = 6-8] 10-12 ICH Yes Yes

Source: Scheeren J, Woolley KL, Dang T, Opportunities and Challenges of Global Drug Development in Asia: Are you ready?,  Regulatoryfocus.org, December 2013

Related pages

  1. European Medicines Agency (EMA)
  2. Food and Drug Administration (FDA)
  3. Historical Events behind Current Regulations
  4. ICH’s GCP Guideline
powered by Related Pages WP plugin

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

My name is Polachai Ernie Sakchalathorn and I’m the guy behind ClinicalResesarchAssociateCRA.com. I have been in clinical research since 2007. Click on my picture above to learn more about my background and experience.

Clinical Trial Basics

  • Drug Development
  • In Vitro Diagnostic Development
  • Medical Device Development
  • Search Results

Industry Players

  • Sponsor
  • Clinical Site
  • Contract Research Organization (CRO)
  • Site Management Organization (SMO)
  • Institutional Review Board (IRB) or Ethics Review Committee (ERC)
  • Regulatory Body
  • Search Results

CRA Career Path

  • What is CRA?
  • Education and Skills Needed
  • How to Get Into a CRA Role
  • Career Development
  • CRA Certification
  • Search Results

Clinical Research Regulations

  • Historical Events behind Current Regulations
  • Food and Drug Administration (FDA)
  • ICH’s GCP Guideline
  • European Medicines Agency (EMA)
  • Country Specific Regulations – Global / International Trial
  • Search Results

Resources

  • Books
  • Jobs
  • ES’ SOCRA CCRP Exam Study Guide
  • Purchasing Multiple Copies of the ES’ SOCRA CCRP Study Guide
  • Email/Download Troublesheet & FAQs for ES’ SOCRA CCRP Study Guide
  • Search Results

Pages

  • Contact
  • About
  • Disclaimer
  • Privacy Policy
  • Affiliate Disclosure
  • Term of Use
  • LICENSE AGREEMENT TERMS
  • Search Results

Copyright © 2023 www.ClinicalResearchAssociateCRA.com